Form 4: Director Theodore R. Samuels II Acquires BMY Shares

Bristol-Myers Squibb director Theodore R. Samuels II acquired 845.012 deferred share units as part of director compensation.

Summary

• Director Theodore R. Samuels II was granted 845.012 deferred share units on March 31, 2026.
• The units were acquired at a price of $60.65 per share.
• Following this transaction, the director holds a total of 68,727.516 deferred share units.
• These units are settleable in common stock upon the director's departure from the board or at a previously specified future date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Demonstrates continued alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Value of deferred share units is subject to the market performance of Bristol-Myers Squibb common stock.

Future Outlook

The deferred share units will convert to common stock upon the director's cessation of service or at a pre-determined future date.

Management Comments

• The transaction reflects standard director compensation practices under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation, which is standard practice for large-cap pharmaceutical companies to ensure board members maintain a long-term equity stake in the firm.

Comparison to Industry Standards

• The use of deferred share units for non-employee directors is consistent with compensation structures at peer companies like Pfizer, Merck, and Eli Lilly.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation event.

Next Steps

• No specific future actions required by the reporting person other than continued board service.

Key Dates

Keywords

Bristol-Myers Squibb, BMY, Insider Trading, Form 4, Director Compensation, Deferred Share Units